Original Article

Epidemiologic Analysis of Drug and Poison Information Center (DPIC) Inquiries: A Four-Year Cross-Sectional Study in Hamadan, Iran (2019-2023)

Abstract

Background: Drug and Poison Information Centers (DPIC) play a pivotal role in pharmacovigilance, public education, and preventing adverse drug reactions, medication errors, and poisoning incidents.

Methods: This study presents an epidemiologic analysis of inquiries received by the DPIC at Hamadan University of Medical Sciences in Iran over four years (2019-2023). A descriptive cross-sectional analysis of recorded phone calls to the DPIC at Hamadan University of Medical Sciences from October 2019 to November 2023. The demographic distribution of inquirers, types of inquiries, and sources used to answer questions were considered in the analysis.

Results: The study reports a total of 3904 recorded calls over the four-year period, with an average of 78.08 calls per month. The majority of callers were female (61%). The top three questions focused on coronavirus, side effects, and drug-drug reactions. Psychiatric agents, gastrointestinal agents, and antibiotics were the top three drug families inquired about. The data were collected from various references, with UptoDate® being the most frequently used (43.3%).

Conclusion: This study provides a comprehensive epidemiologic analysis of inquiries received by the DPIC at Hamadan University of Medical Sciences. The findings underscore the importance of DPICs in providing evidence-based information, contributing to pharmacovigilance, and enhancing patient safety.

Saheb Sharif-Askari F, Saheb Sharif-Askari N, Javadi M, Gholami K. Adverse drug reactions reported to the drug and poison information center of Tehran, Iran. PloS One. 2017;12(9):e0185450.
2. Maruzi A, Sabbaghian-Tousi S, Karimi G, Jabbari R, Elyasi S. A Ten-year Report of Drug and Poison Information Center in Mashhad, Iran 2007-2017. Iran J Pharm Res. 2021;20(1):53-61.
3. Karimzadeh I, Vazin A, Talebnia N, Hatami-Mazinani N, Mahi-Birjand M. Performance of drug and poison information center within a Referral University hospital in southwest of Iran. J Pharm Care. 2017:49-55.
4. Rosenberg JM, Koumis T, Nathan JP, Cicero LA, McGuire H. Current status of pharmacist-operated drug information centers in the United States. Am J Health Syst Pharm. 2004;61(19):2023-32.
5. Inácio P, Cavaco A, Airaksinen M. The value of patient reporting to the pharmacovigilance system: a systematic review. Br J Clin Pharmacol. 2017;83(2):227-46.
6. Bencheikh RS, Benabdallah G. Medication errors: pharmacovigilance centres in detection and prevention. Br J Clin Pharmacol. 2009;67(6):687-90.
7. Shadnia S, Soltaninejad K, Sohrabi F, Rezvani M, Barari B, Abdollahi M. The performance of loghman-hakim drug and poison information center from 2006 to 2008. Iran J Pharm Res. 2011;10(3):647-52.
8. Ghane T, Behmanesh Y, Khazei F. Annual Report of Drug and Poison Information in Iran From March 2012 to March 2013. Acta Medica Iranica. 2016;54(8):525-9.
9. Pohjanoksa-Mäntylä MK, Antila J, Eerikäinen S, et al. Utilization of a community pharmacy-operated national drug information call center in Finland. Res Social Adm Pharm. 2008;4(2):144-52.
10. Ghane T, Haghgoo S, Adib N. Evaluation of recorded phone calls to Iran’s Drug and Poison Information Centers: a 4 years’ study. Medical Science Journal of Islamic Azad Univesity-Tehran Medical Branch. 2023;33(4):435-42.
11. Bouvy ML, van Berkel J, de Roos-Huisman CM, Meijboom RH. Patients' drug-information needs: a brief view on questions asked by telephone and on the Internet. Pharm World Sci. 2002;24(2):43-5.
12. Lau SR, Waldorff F. Disentangling concepts of inappropriate polypharmacy in old age: a scoping review. BMC Public Health. 2023;23(1):245.
13. Kitaw TA, Haile RN. Prevalence of polypharmacy among older adults in Ethiopia: a systematic review and meta-analysis. Sci Rep. 2023;13(1):17641.
14. Soleymani F, Taheri F, Roughead E, Nikfar S, Abdollahi M. Pattern of Antidepressant Utilization and Cost in Iran from 2006 to 2013 in Comparison with Other Countries. J Epidemiol Glob Health. 2018;8(3-4):213-9.
15. Entezari-Maleki T, Taraz M, Javadi MR, et al. A two-year utilization of the pharmacist-operated drug information center in Iran. J Res Pharm Pract. 2014;3(4):117-22.
16. Ghane T, Behmanesh Y, Khazaei F. Annual Report of Recorded Phone Calls to Iran's Drug and Poison Information Centers (2014-2015). 2015.
17. Asiri YA, Al-Arifi MN, Al-Sultan MS, Gubara OA. Evaluation of drug and poison information center in Saudi Arabia during the period 2000-2002. Saudi Med J. 2007;28(4):617-9.
18. Mountford CM, Lee T, de Lemos J, Loewen PS. Quality and usability of common drug information databases. Can J Hosp Pharm. 2010;63(2):130-7.
19. Moorman KL, Macdonald EA. Assessment and use of drug information references in Utah pharmacies. Pharm Pract (Granada). 2017;15(1):839.
20. Scaffidi MA, Khan R. Comparison of the Impact of Wikipedia, UpToDate, and a Digital Textbook on Short-Term Knowledge Acquisition Among Medical Students: Randomized Controlled Trial of Three Web-Based Resources. JMIR Med Educ. 2017;3(2):e20.
21. Khadem Rezaiyan M, Afshari R. Epidemiology of poisoning in northeast of Iran (2004-2013). Int J Med Toxicol Forensic Med. 2017;7:54-8.
22. Azami-Aghdash S, Mohseni M, Etemadi M, Royani S, Moosavi A, Nakhaee M. Prevalence and cause of self-medication in Iran: a systematic review and meta-analysis article. Iran J Public Health. 2015;44(12):1580.
23. Zargarzadeh AH, Minaeiyan M, Torabi A. Prescription and nonprescription drug use in Isfahan, Iran: an observational, cross-sectional study. Curr Ther Res Clin Exp. 2008;69(1):76-87.
Files
IssueVol 12, No 2 (Spring 2024) QRcode
SectionOriginal Article(s)
Keywords
Medication Error; Pharmacovigilance; Epidemiology

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Ghalandari N, Emami S. Epidemiologic Analysis of Drug and Poison Information Center (DPIC) Inquiries: A Four-Year Cross-Sectional Study in Hamadan, Iran (2019-2023). J Pharm Care. 2024;12(2):113-118.